<DOC>
	<DOCNO>NCT01397968</DOCNO>
	<brief_summary>This study evaluate efficacy YKP3089 reduce seizure frequency compare baseline subject partial onset seizure fully control despite treatment 1 3 concomitant anti-epileptic drug . Also evaluate safety tolerability YKP3089 .</brief_summary>
	<brief_title>Efficacy Safety YKP3089 Subjects With Treatment Resistant Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<criteria>Diagnosis treatment resistant partial epilepsy ; History epilepsy least 2 year ; Have least 3 simple partial motor component , complex partial secondarily generalize seizure per month consecutive 21 day seizure free period . Currently treat stable dose : 1 3 AED 's least 12 week prior randomization . VNS count AED ; however parameter must remain stable least 4 week prior baseline . Benzodiazepines take least per week epilepsy , anxiety sleep disorder , count 1 AED . Therefore maximum two additional approve AEDs allow . 1 . A history alcoholism , drug abuse , drug addiction within past 2 year . 2 . Subject status epilepticus within past 1 year . 3 . Subject great 2 allergic reaction AED one serious hypersensitivity reaction AED . 4 . Subjects take felbamate le 18 month continuous exposure . 5 . Subjects receive phenytoin , phenobarbitone metabolite drug . 6 . No active suicidal plan/intent active suicidal thought past 6 month . 7 . History suicide attempt last 2 year ; 1 lifetime suicide attempt . 8 . Subject meet criteria current major depressive episode ( within 6 month ) . 9 . Use intermittent rescue benzodiazepine once/month ( 12 dose 24hour period consider one rescue ) one month period prior Visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>partial onset seizure</keyword>
	<keyword>treatment resistant</keyword>
	<keyword>partial epilepsy</keyword>
</DOC>